Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Beta Drugs Ltd
Your Vote -
Buy
75.00%
Hold
12.50%
Sell
12.50%
75.00%
8 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Beta Drugs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Beta Drugs Q4 net profit zooms 283.45% at Rs 5.33 cr
-
Beta Drugs - Statement of deviation(s) or variation(s) under Reg. 32
-
Beta Drugs - Monitoring Agency Report
-
Beta Drugs - Outcome of Board Meeting
-
Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates
-
Beta Drugs - Outcome of Board Meeting
-
Beta Drugs - General Updates
-
Beta Drugs - Disclosure under SEBI Takeover Regulations
-
Beta Drugs - Price movement
-
Beta Drugs - Price movement
-
Beta Drugs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Beta Drugs - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Beta Drugs - General Updates
-
Beta Drugs - Trading Window
-
Beta Drugs - General Updates
-
Beta Drugs - General Updates
-
Beta Drugs - Copy of Newspaper Publication
-
Beta Drugs Q3 net profit zooms 333.33% at Rs 3.25 cr
Key fundamentals
Evaluate the intrinsic value of Beta Drugs Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 279.9453 | 252.8384 | 119.6301 | 99.984 | 82.6124 |
| Liabilities | 279.9453 | 252.8384 | 119.6301 | 99.984 | 82.6124 |
| Equity | 10.1369 | 10.0945 | 9.6138 | 9.6138 | 9.6138 |
| Gross Profit | 28.5444 | 31.416 | 33.5256 | 31.1981 | 25.1837 |
| Net Profit | 14.3345 | 15.4321 | 21.9366 | 18.8161 | 14.2465 |
| Cash From Operating Activities | 19.1973 | 18.0425 | 21.1872 | 10.2264 | 18.7625 |
| NPM(%) | 6.35 | 7 | 11.1 | 11.91 | 11.41 |
| Revenue | 225.4295 | 220.1996 | 197.6207 | 157.8746 | 124.8468 |
| Expenses | 196.885 | 188.7835 | 164.0951 | 126.6765 | 99.6631 |
| ROE(%) | 6.23 | 6.71 | 9.54 | 8.18 | 6.19 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Beta Drugs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 720.85 | 2.41 | 0.00 | 0.00 | -26.19 | 0.69 |
| Lotus Eye Hospital and Institute Ltd | 106.56 | -4.06 | 343.74 | 0.00 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 7.07 | 1.73 | 0.00 | 0.00 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 675.80 | 2.83 | 0.00 | 0.00 | -363.15 | 0.00 |
Company Info
The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24, 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2005 -Incorporation of the Company as Beta Drugs Private Limited 2014 -Vijay Kumar Batra, existing promoter took over the Company 2015 -ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules -Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh 2016 -Certificate of Good Manufacturing Practice from Republic of Kenya 2017 -Conversion of Company into Public Limited Company. 2024 -The Company Earns Forbes Asia ""Best Under a Billion"" 2024 Award for Third Consecutive Year, 2025 -The Company has issued Bonus Shares in the Ratio of 1:20.
The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24, 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2005 -Incorporation of the Company as Beta Drugs Private Limited 2014 -Vijay Kumar Batra, existing promoter took over the Company 2015 -ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules -Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh 2016 -Certificate of Good Manufacturing Practice from Republic of Kenya 2017 -Conversion of Company into Public Limited Company. 2024 -The Company Earns Forbes Asia ""Best Under a Billion"" 2024 Award for Third Consecutive Year, 2025 -The Company has issued Bonus Shares in the Ratio of 1:20.
Read More
Parent Organisation
Beta Drugs Ltd.
Founded
21/09/2015
Managing Director
Mr.Varun Batra
NSE Symbol
BETAEQ
FAQ
The current price of Beta Drugs Ltd is
The 52-week high for Beta Drugs Ltd is
The market capitalization of Beta Drugs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Beta Drugs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Beta Drugs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Beta Drugs Ltd shares.
The CEO of Beta Drugs Ltd is Mr.Varun Batra, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
